expenses also increasing due to Otrexup pre-launch activities. Nothing new.
The post is true. For that it earned three red thumbs, with more to come, possibly. It goes to show that truth does hurt.
On to the CC.
wow! listen to your optimism.you must be looking for a 3 penny gain today where you can sell then start bashing again.
Report is fine...
I expect short lasting down pressure at open..and then we end higher....this is the last earnings report before FDA approval (expected). If all is on track from the CEO, we should be fine
aww, this isn't gonna be a pretty day.. -0.04 vs. -0.03
Immaterial. This company is about upcoming prospects and not a loss of .04 vs .03 estimate